Binhui Biotech is based in Wuhan, China. It has raised $537M in total funding. Latest round: Series B.
Binhui Biotech is based in Wuhan, China. Binhui Biotech has raised $537M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in April 2022. The round record for Binhui Biotech runs through 2022; nothing later has been disclosed. Investors on record include Yangtze River Pharmaceutical Group, DNV Capital, Jointown Pharmaceutical Group, Ming Capital, Hubei Provincial High-Tech Industry Investment Group. 5 distinct backers are named across the disclosed rounds.
Binhui Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Wuhan below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026